Plaxone 250mg/125mg Injection
Marketer
Shiron Pharmaceuticals
Salt Composition
Ceftriaxone (250mg) + Sulbactam (125mg)
Overview Plaxone 250mg/125mg Injection
Combiflox, a 250mg/125mg injectable formulation, combats diverse bacterial infections. Its mechanism halts microbial proliferation, curbing infection spread. Administration requires strict medical oversight; adherence to the prescribed schedule is crucial. Complete the treatment regimen, regardless of symptom improvement, as premature cessation can compromise efficacy. Nausea, vomiting, diarrhea, and indigestion are potential side effects; worsening symptoms necessitate immediate medical attention. Seek emergency care for allergic reactions (e.g., rashes, itching, swelling, dyspnea). Disclose all medications to your physician before initiating treatment; pregnant or lactating individuals require prior consultation. Alcohol consumption should be avoided due to potential increased drowsiness. While generally non-impairing, driving is discouraged if drowsiness or dizziness occur. Adequate rest, nutrition, and hydration contribute to faster recovery. Monitoring may involve diagnostic testing to assess treatment response.
Uses of Plaxone 250mg/125mg Injection
Infections caused by bacteria
Major Benefits of Plaxone 250mg/125mg Injection:
The medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Plaxone 250mg/125mg Injection:
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Rash
- Diarrhea
- Increased liver enzymes
- Injection site reactions (pain, swelling, redness)
How to use Plaxone 250mg/125mg Injection:
This medication will be administered by your healthcare provider; self-medication is strongly discouraged.
How Plaxone 250mg/125mg Injection works:
Ceftriaxone/Sulbactam 250mg/125mg injection (Plaxone) combines the antibiotic Ceftriaxone with the beta-lactamase inhibitor Sulbactam. Ceftriaxone's mechanism involves disrupting bacterial cell wall synthesis, a crucial process for bacterial viability. Sulbactam counteracts bacterial resistance mechanisms, thereby boosting Ceftriaxone's effectiveness.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse reactions associated with the concurrent use of Plaxone 250mg/125mg Injection and alcohol.
PregnancySAFE IF PRESCRIBED
The injectable medication Plaxone 250mg/125mg is typically deemed safe for pregnant individuals. Preclinical trials in animals revealed minimal or no harm to offspring; nevertheless, data from human clinical trials remain scarce.
Breast feedingCAUTION
The administration of Plaxone 250mg/125mg Injection to breastfeeding mothers requires careful consideration. Lactation should be temporarily discontinued throughout the mother's treatment course and until the medication is fully cleared from her system.
DrivingUNSAFE
The injection Plaxone 250mg/125mg can cause drowsiness, blurred vision, and dizziness. Refrain from driving if you experience these side effects.
KidneyCONSULT YOUR DOCTOR
Data regarding Plaxone 250mg/125mg Injection use in individuals with renal impairment is scarce. Physician consultation is advised.
LiverCAUTION
Administering Plaxone 250mg/125mg Injection requires careful consideration in individuals with severe hepatic impairment; dosage modification may be necessary. Consult a physician for guidance. Dosage alteration for Plaxone 250mg/125mg Injection is not advised for patients exhibiting mild or moderate liver dysfunction.
What if you forget to take Plaxone 250mg/125mg Injection :
Omitting a scheduled dose of Plaxone 250mg/125mg Injection requires contacting your physician.
Facts to Know About Plaxone 250mg/125mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobials |
3,018 People bought this recently